Back Cover - Nanovaccines: Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy (Adv. Mater. 7/2017)

Research output: Non-textual formDigital or Visual ProductsSolo art productionpeer-review

Abstract

In article 1603239, Flavia Fontana, Hélder A. Santos, and co-workers develop an innovative cancer nanovaccine by merging the adjuvant properties of the nanoparticles produced by nanoprecipitation in a microfluidic glass capillary device with high reproducibility, together with a biomimetic source of antigens derived from cancer-cell membranes. The nanovectors induce maturation of antigen-presenting cells and secretion of pro-inflammatory cytokines in vitro.
Original languageEnglish
DOIs
Publication statusPublished - 13 Feb 2017
MoE publication typeF1 Published independent work of art

Fields of Science

  • 221 Nano-technology

Cite this

@misc{374644d724cf4d0dbcc64cb0f3ca1fb3,
title = "Back Cover - Nanovaccines: Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy (Adv. Mater. 7/2017)",
abstract = "In article 1603239, Flavia Fontana, H{\'e}lder A. Santos, and co-workers develop an innovative cancer nanovaccine by merging the adjuvant properties of the nanoparticles produced by nanoprecipitation in a microfluidic glass capillary device with high reproducibility, together with a biomimetic source of antigens derived from cancer-cell membranes. The nanovectors induce maturation of antigen-presenting cells and secretion of pro-inflammatory cytokines in vitro.",
keywords = "221 Nano-technology",
author = "Flavia Fontana and Mohammad-Ali Shahbazi and Dongfei Liu and Hongbo Zhang and Ermei M{\"a}kil{\"a} and Jarno Salonen and Hirvonen, {Jouni Tapio} and {Almeida Santos}, Helder",
year = "2017",
month = "2",
day = "13",
doi = "10.1002/adma.201770049",
language = "English",

}

TY - ADVS

T1 - Back Cover - Nanovaccines: Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy (Adv. Mater. 7/2017)

AU - Fontana, Flavia

AU - Shahbazi, Mohammad-Ali

AU - Liu, Dongfei

AU - Zhang, Hongbo

AU - Mäkilä, Ermei

AU - Salonen, Jarno

AU - Hirvonen, Jouni Tapio

AU - Almeida Santos, Helder

PY - 2017/2/13

Y1 - 2017/2/13

N2 - In article 1603239, Flavia Fontana, Hélder A. Santos, and co-workers develop an innovative cancer nanovaccine by merging the adjuvant properties of the nanoparticles produced by nanoprecipitation in a microfluidic glass capillary device with high reproducibility, together with a biomimetic source of antigens derived from cancer-cell membranes. The nanovectors induce maturation of antigen-presenting cells and secretion of pro-inflammatory cytokines in vitro.

AB - In article 1603239, Flavia Fontana, Hélder A. Santos, and co-workers develop an innovative cancer nanovaccine by merging the adjuvant properties of the nanoparticles produced by nanoprecipitation in a microfluidic glass capillary device with high reproducibility, together with a biomimetic source of antigens derived from cancer-cell membranes. The nanovectors induce maturation of antigen-presenting cells and secretion of pro-inflammatory cytokines in vitro.

KW - 221 Nano-technology

UR - http://onlinelibrary.wiley.com/journal/10.1002/%28ISSN%291521-4095

U2 - 10.1002/adma.201770049

DO - 10.1002/adma.201770049

M3 - Digital or Visual Products

ER -